1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. North America Parenteral Nutrition Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. North America Parenteral Nutrition Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1 Growing prevalence of gastrointestinal diseases drives the parenteral nutrition market.
5.2 Market Opportunities
- 5.2.1 New product development of nutrition is anticipated to create opportunities for the market growth during the forecast period.
5.3 Future Trends
- 5.3.1 Innovation in formulations of nutrition products act as future growth trends in the parenteral medical nutrition market.
5.4 Impact of Drivers and Restraints
6. North America Parenteral Nutrition Market Regional Analysis
6.1 North America Parenteral Nutrition Market Overview
6.2 North America Parenteral Nutrition Market Revenue 2020-2030 (US$ Million)
6.3 North America Parenteral Nutrition Market Forecast Analysis
7. North America Parenteral Nutrition Market Analysis – by Nutrient Type
7.1 Single Dose Amino Acid Solution
- 7.1.1 Overview
- 7.1.2 Single Dose Amino Acid Solution: North America Parenteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Parenteral Lipid Emulsion
- 7.2.1 Overview
- 7.2.2 Parenteral Lipid Emulsion: North America Parenteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Carbohydrates
- 7.3.1 Overview
- 7.3.2 Carbohydrates: North America Parenteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Trace Elements
- 7.4.1 Overview
- 7.4.2 Trace Elements: North America Parenteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Vitamins & Minerals
- 7.5.1 Overview
- 7.5.2 Vitamins & Minerals: North America Parenteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
8. North America Parenteral Nutrition Market Analysis – by End User
8.1 Hospitals
- 8.1.1 Overview
- 8.1.2 Hospitals: North America Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
8.2 Clinics
- 8.2.1 Overview
- 8.2.2 Clinics: North America Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
9. North America Parenteral Nutrition Market – North America Analysis
9.1 North America
- 9.1.1 North America Parenteral Nutrition Market Breakdown, by Key
Country, 2023 and 2030 (%)
- 9.1.1.1 North America Parenteral Nutrition Market – Revenue and
Forecast Analysis – by Country
- 9.1.1.1 US:
North America Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
- 9.1.1.1.1 US: North America Parenteral Nutrition Market Breakdown, by Nutrient Type
- 9.1.1.1.2 US: North America Parenteral Nutrition Market Breakdown, by End User
- 9.1.1.2 Canada:
North America Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
- 9.1.1.2.1 Canada: North America Parenteral Nutrition Market Breakdown, by Nutrient Type
- 9.1.1.2.2 Canada: North America Parenteral Nutrition Market Breakdown, by End User
- 9.1.1.3 Mexico :
North America Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
- 9.1.1.3.1 Mexico : North America Parenteral Nutrition Market Breakdown, by Nutrient Type
- 9.1.1.3.2 Mexico : North America Parenteral Nutrition Market Breakdown, by End User
10. Competitive Landscape
10.1 Heat Map Analysis
10.2 Company Positioning and Concentration
11. North America Parenteral Nutrition Market Industry Landscape
11.1 Overview
11.2 Mergers and Acquisitions
11.3 Agreements, Collaborations, and Joint Ventures
11.4 New Product Launches
11.5 Expansions and Other Strategic Developments
12. Company Profiles
12.1 ICU Medical Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Grifols SA
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Pfizer Inc
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Otsuka Pharmaceuticals Co Ltd
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Baxter International Inc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 B Braun SE
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Fresenius Kabi AG
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Aculife Healthcare Pvt Ltd
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Vifor Pharma Management AG
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
13. Appendix
13.1 About Business Market Insights
Get Free Sample For North America Parenteral Nutrition Market
